David Rowley

7.4k total citations
206 papers, 5.7k citations indexed

About

David Rowley is a scholar working on Immunology, Endocrinology and Molecular Biology. According to data from OpenAlex, David Rowley has authored 206 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Immunology, 67 papers in Endocrinology and 61 papers in Molecular Biology. Recurrent topics in David Rowley's work include Escherichia coli research studies (42 papers), Vibrio bacteria research studies (39 papers) and Aquaculture disease management and microbiota (31 papers). David Rowley is often cited by papers focused on Escherichia coli research studies (42 papers), Vibrio bacteria research studies (39 papers) and Aquaculture disease management and microbiota (31 papers). David Rowley collaborates with scholars based in United States, Australia and South Africa. David Rowley's co-authors include C. R. Jenkin, CR Jenkin, Stephen R. Attridge, David R. Nelson, Marta Gómez-Chiarri, Wenjing Zhao, Murni Karim, Margaret E. Teasdale, S. H. Neoh and Paul B. Beeson and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Investigation.

In The Last Decade

David Rowley

198 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Rowley United States 42 1.6k 1.4k 1.2k 944 742 206 5.7k
Johnny W. Peterson United States 39 1.6k 1.0× 1.3k 0.9× 1.2k 1.0× 626 0.7× 652 0.9× 147 4.4k
N A Buchmeier United States 26 1.6k 1.0× 848 0.6× 1.1k 0.9× 1.3k 1.4× 1.1k 1.5× 30 4.5k
C W Moss United States 42 2.4k 1.5× 490 0.3× 1.3k 1.0× 837 0.9× 1.0k 1.4× 160 6.2k
Otto Holst Germany 50 3.2k 2.0× 1.6k 1.1× 930 0.7× 734 0.8× 742 1.0× 179 7.4k
J. Glenn Morris United States 43 961 0.6× 1.3k 0.9× 2.5k 2.0× 1.2k 1.3× 749 1.0× 111 5.0k
Donald G. Guiney United States 39 1.8k 1.1× 917 0.6× 1.1k 0.9× 1.3k 1.4× 718 1.0× 73 5.0k
Michio Ohta Japan 37 1.8k 1.1× 644 0.4× 645 0.5× 364 0.4× 1.0k 1.4× 217 4.5k
Paul S. Hoffman United States 47 2.4k 1.5× 1.1k 0.7× 1.5k 1.2× 503 0.5× 1.2k 1.7× 132 6.2k
Klaus Hantke Germany 59 4.6k 2.8× 497 0.3× 1.4k 1.1× 814 0.9× 848 1.1× 108 10.2k
Antonio Molinaro Italy 50 4.5k 2.7× 1.5k 1.0× 775 0.6× 910 1.0× 502 0.7× 353 9.7k

Countries citing papers authored by David Rowley

Since Specialization
Citations

This map shows the geographic impact of David Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rowley more than expected).

Fields of papers citing papers by David Rowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rowley. The network helps show where David Rowley may publish in the future.

Co-authorship network of co-authors of David Rowley

This figure shows the co-authorship network connecting the top 25 collaborators of David Rowley. A scholar is included among the top collaborators of David Rowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rowley. David Rowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, Meredith M., et al.. (2023). Development and evaluation of a formulation of probiont Phaeobacter inhibens S4 for the management of vibriosis in bivalve hatcheries. SHILAP Revista de lepidopterología. 3(3). 256–267. 4 indexed citations
2.
Wu, Christine, Andrew M. Kim, Robert Literman, et al.. (2022). Screening the PRISM Library against Staphylococcus aureus Reveals a Sesquiterpene Lactone from Liriodendron tulipifera with Inhibitory Activity. ACS Omega. 7(40). 35677–35685. 1 indexed citations
3.
Chen, Jun, Pengfu Liu, Xiaohe Chu, et al.. (2020). Metabolic Pathway Construction and Optimization of Escherichia coli for High-Level Ectoine Production. Current Microbiology. 77(8). 1412–1418. 17 indexed citations
4.
Sun, Jiadong, Zhiyuan Peng, Christina Khoo, et al.. (2019). Pectic Oligosaccharides from Cranberry Prevent Quiescence and Persistence in the Uropathogenic Escherichia coli CFT073. Scientific Reports. 9(1). 19590–19590. 15 indexed citations
5.
Wu, Qihao, Gaiyun Zhang, Bixia Wang, et al.. (2018). Albisporachelin, a New Hydroxamate Type Siderophore from the Deep Ocean Sediment-Derived Actinomycete Amycolatopsis albispora WP1T. Marine Drugs. 16(6). 199–199. 15 indexed citations
6.
Sun, Jiadong, Weixi Liu, Hang Ma, et al.. (2016). Effect of cranberry (Vaccinium macrocarpon) oligosaccharides on the formation of advanced glycation end-products. Journal of Berry Research. 6(2). 149–158. 25 indexed citations
7.
Rowley, David. (2014). A heated debate on TPD. 6. 1 indexed citations
8.
Rowley, David. (2014). The illiquidity premium. 10. 3 indexed citations
9.
El‐Sayed, Naglaa Salem, Amir Nasrolahi Shirazi, Ahmed K. El‐Ziaty, et al.. (2014). Synthesis of 4-aryl-6-indolylpyridine-3-carbonitriles and evaluation of their antiproliferative activity. Tetrahedron Letters. 55(6). 1154–1158. 36 indexed citations
10.
Graff, Jason R., et al.. (2013). Vibrio cholerae Exploits Sub-Lethal Concentrations of a Competitor-Produced Antibiotic to Avoid Toxic Interactions. Frontiers in Microbiology. 4. 8–8. 26 indexed citations
11.
Prieto‐Davó, Alejandra, Luis Jesús Villarreal-Gómez, Alan T. Bull, et al.. (2013). Targeted search for actinomycetes from nearshore and deep-sea marine sediments. FEMS Microbiology Ecology. 84(3). 510–518. 30 indexed citations
12.
Choi, Hyukjae, Samantha J. Mascuch, Francisco A. Villa, et al.. (2012). Honaucins A−C, Potent Inhibitors of Inflammation and Bacterial Quorum Sensing: Synthetic Derivatives and Structure-Activity Relationships. Chemistry & Biology. 19(5). 589–598. 85 indexed citations
13.
Rowley, David. (1991). The early history of the Australian Society for Immunology. Immunology and Cell Biology. 69(5). 307–308.
14.
LaBrooy, J T, et al.. (1989). Assays for total and antigen-specific polymeric IgA in serum based on binding to secretory component. Journal of Immunological Methods. 117(2). 247–255. 4 indexed citations
15.
Mathan, V. I., et al.. (1988). Bacterial lipopolysaccharide-induced intestinal microvascular lesions leading to acute diarrhea.. Journal of Clinical Investigation. 82(5). 1714–1721. 43 indexed citations
16.
Hackett, Jamie A., Stephen R. Attridge, & David Rowley. (1988). Oral Immunization with Live, Avirulent fla+ Strains of Salmonella Protects Mice Against Subsequent Oral Challenge with Salmonella typhimurium. The Journal of Infectious Diseases. 157(1). 78–84. 14 indexed citations
17.
Rowley, David, KJ Turner, & CR Jenkin. (1964). THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. Immunology and Cell Biology. 42(2). 237–248. 72 indexed citations
18.
Ravin, Herbert A., David Rowley, Cheryl Jenkins, & J. Fine. (1960). ON THE ABSORPTION OF BACTERIAL ENDOTOXIN FROM THE GASTRO-INTESTINAL TRACT OF THE NORMAL AND SHOCKED ANIMAL. The Journal of Experimental Medicine. 112(5). 783–792. 192 indexed citations
19.
Beeson, Paul B. & David Rowley. (1959). THE ANTICOMPLEMENTARY EFFECT OF KIDNEY TISSUE. The Journal of Experimental Medicine. 110(5). 685–697. 116 indexed citations
20.
Manten, A.A. & David Rowley. (1953). Influence of chloramphenicol and specific antiserum on the variability of the K 12 strain of Bact. coli.. PubMed Central. 34(1). 23–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johnny W. Peterson Breakdown of academic impact, for papers by N A Buchmeier Breakdown of academic impact, for papers by C W Moss Breakdown of academic impact, for papers by Otto Holst Breakdown of academic impact, for papers by J. Glenn Morris Breakdown of academic impact, for papers by Donald G. Guiney Breakdown of academic impact, for papers by Michio Ohta Breakdown of academic impact, for papers by Paul S. Hoffman Breakdown of academic impact, for papers by Klaus Hantke Breakdown of academic impact, for papers by Antonio Molinaro
Rankless by CCL
2026